Relay Therapeutics

RLAY

NASDAQHealth Care

Income Statement

Total Revenue$10.01M

Gross Profit$10.01M

Operating Income$-385.67M

EBITDA$-332.24M

EBIT$-337.71M

Pre-tax Income$-276.48M

Net Income$-337.71M

Cash Equivalent$143.32M

Total Debt$50.43M

Book Value$761.04M

Book Value Per Share5.39

Return on Equity (ROE)-43.42%

Return on Assets (ROA)-38.76%

Return on Invested Capital (ROI)-43.42%

Net Profit Margin-3374.72%

Current Ratio15.95

Quick Ratio15.61

Long-Term Debt / Equitynull